{"id":{"repo_id":"utahstate","oai_identifier":"oai:digitalcommons.usu.edu:etd-5657"},"canonical_url":"https://search.ndltd.org/etd/utahstate/oai:digitalcommons.usu.edu:etd-5657","repository":{"repo_id":"utahstate","name":"Utah State University","base_url":"https://digitalcommons.usu.edu/do/oai/"},"display":{"title":"Natural Killer Activity in Gardner's Syndrome","abstract":"Gardner's syndrome is an autosomal dominant disease presenting multiple colonic polyps with a predisposition for malignant change. In addition to colonic polyp formation by early adolescence, extracolonic lesions appear often prior to polyp formation. One theoretical mechanism for the origin of polyps and malignancies in Gardner's syndrome is a genetic defect in the natural killer cell activity of patients with this disease. Natural killer cells are a subpopulation of lymphocytes that spontaneously lyse tumor cells and virally transformed cells. A study was undertaken to determine the natural killer activity of patients with Gardner's syndrome. A technique termed chromium release was used to determine natural killer cell reactivity. This assay involves incubating patient's lymphocytes (effector cells) with tumor cells from a myelogenous leukemia cell line (target cells) which has been previously labeled with the radioactive isotope chromium-51. The level of isotope in the supernatant is believed to correlate with the natural killer activity of the subject. The results of this study indicate normal natural killer cell activity in patients with Gardner's syndrome. A trend toward lower natural killer cell activity was found at higher effector to target ratios in the patients. An incidental finding of higher natural killer activity in males (patients and healthy subjects) than in females was made. Higher natural killer cell activity of male lymphocytes against the cell line K562 has not been previously reported. In conclusion, the natural killer cell activity of lymphocytes from patients with Gardner's syndrome against the cell line K562, is no different from that found by lymphocytes of healthy subjects.","abstract_html":"Gardner&#x27;s syndrome is an autosomal dominant disease presenting multiple colonic polyps with a predisposition for malignant change. In addition to colonic polyp formation by early adolescence, extracolonic lesions appear often prior to polyp formation. One theoretical mechanism for the origin of polyps and malignancies in Gardner&#x27;s syndrome is a genetic defect in the natural killer cell activity of patients with this disease. Natural killer cells are a subpopulation of lymphocytes that spontaneously lyse tumor cells and virally transformed cells. A study was undertaken to determine the natural killer activity of patients with Gardner&#x27;s syndrome. A technique termed chromium release was used to determine natural killer cell reactivity. This assay involves incubating patient&#x27;s lymphocytes (effector cells) with tumor cells from a myelogenous leukemia cell line (target cells) which has been previously labeled with the radioactive isotope chromium-51. The level of isotope in the supernatant is believed to correlate with the natural killer activity of the subject. The results of this study indicate normal natural killer cell activity in patients with Gardner&#x27;s syndrome. A trend toward lower natural killer cell activity was found at higher effector to target ratios in the patients. An incidental finding of higher natural killer activity in males (patients and healthy subjects) than in females was made. Higher natural killer cell activity of male lymphocytes against the cell line K562 has not been previously reported. In conclusion, the natural killer cell activity of lymphocytes from patients with Gardner&#x27;s syndrome against the cell line K562, is no different from that found by lymphocytes of healthy subjects.","abstract_has_math":false,"creators":["Stembridge, Ann Marie"],"institution":"Hosted by Utah State University Libraries","degree_name":"Master of Science (MS)","degree_level":"Thesis","degree_discipline":"Biology","degree_department":null,"school":null,"contributors":["Reed Warren","John Simmons","Wilbur Thain"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T08:56:46Z","subjects":["Gardner's Syndrome","autosomal dominant disease","natural killer cell","genetic defect","Biology","Genetics","Immunology and Infectious Disease"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier.doi","label":"DOI","values":["https://doi.org/10.26076/700c-b10d"],"render_values":[{"text":"https://doi.org/10.26076/700c-b10d","href":"https://doi.org/10.26076/700c-b10d","code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://digitalcommons.usu.edu/etd/4623","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://digitalcommons.usu.edu/etd/4623","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://digitalcommons.usu.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adigitalcommons.usu.edu%3Aetd-5657","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Reed Warren","John Simmons","Wilbur Thain"]},{"key":"dc:creator","label":"Author","values":["Stembridge, Ann Marie"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["1982-01-01T08:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["1983-05-01T07:00:00Z"]},{"key":"dc:publisher","label":"Institution","values":["Hosted by Utah State University Libraries"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Biology"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science (MS)"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Gardner's Syndrome","autosomal dominant disease","natural killer cell","genetic defect","Biology","Genetics","Immunology and Infectious Disease"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://digitalcommons.usu.edu/etd/4623"]},{"key":"dc:identifier.doi","label":"DOI","values":["https://doi.org/10.26076/700c-b10d"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Gardner's syndrome is an autosomal dominant disease presenting multiple colonic polyps with a predisposition for malignant change. In addition to colonic polyp formation by early adolescence, extracolonic lesions appear often prior to polyp formation. One theoretical mechanism for the origin of polyps and malignancies in Gardner's syndrome is a genetic defect in the natural killer cell activity of patients with this disease. Natural killer cells are a subpopulation of lymphocytes that spontaneously lyse tumor cells and virally transformed cells. A study was undertaken to determine the natural killer activity of patients with Gardner's syndrome. A technique termed chromium release was used to determine natural killer cell reactivity. This assay involves incubating patient's lymphocytes (effector cells) with tumor cells from a myelogenous leukemia cell line (target cells) which has been previously labeled with the radioactive isotope chromium-51. The level of isotope in the supernatant is believed to correlate with the natural killer activity of the subject. The results of this study indicate normal natural killer cell activity in patients with Gardner's syndrome. A trend toward lower natural killer cell activity was found at higher effector to target ratios in the patients. An incidental finding of higher natural killer activity in males (patients and healthy subjects) than in females was made. Higher natural killer cell activity of male lymphocytes against the cell line K562 has not been previously reported. In conclusion, the natural killer cell activity of lymphocytes from patients with Gardner's syndrome against the cell line K562, is no different from that found by lymphocytes of healthy subjects."]},{"key":"dc:title","label":"Title","values":["Natural Killer Activity in Gardner's Syndrome"]}]}],"canonical_facts":{"dc:contributor":["Reed Warren","John Simmons","Wilbur Thain"],"dc:creator":["Stembridge, Ann Marie"],"dc:date.available":["1982-01-01T08:00:00Z"],"dc:date.created":["1983-05-01T07:00:00Z"],"dc:description.abstract":["Gardner's syndrome is an autosomal dominant disease presenting multiple colonic polyps with a predisposition for malignant change. In addition to colonic polyp formation by early adolescence, extracolonic lesions appear often prior to polyp formation. One theoretical mechanism for the origin of polyps and malignancies in Gardner's syndrome is a genetic defect in the natural killer cell activity of patients with this disease. Natural killer cells are a subpopulation of lymphocytes that spontaneously lyse tumor cells and virally transformed cells. A study was undertaken to determine the natural killer activity of patients with Gardner's syndrome. A technique termed chromium release was used to determine natural killer cell reactivity. This assay involves incubating patient's lymphocytes (effector cells) with tumor cells from a myelogenous leukemia cell line (target cells) which has been previously labeled with the radioactive isotope chromium-51. The level of isotope in the supernatant is believed to correlate with the natural killer activity of the subject. The results of this study indicate normal natural killer cell activity in patients with Gardner's syndrome. A trend toward lower natural killer cell activity was found at higher effector to target ratios in the patients. An incidental finding of higher natural killer activity in males (patients and healthy subjects) than in females was made. Higher natural killer cell activity of male lymphocytes against the cell line K562 has not been previously reported. In conclusion, the natural killer cell activity of lymphocytes from patients with Gardner's syndrome against the cell line K562, is no different from that found by lymphocytes of healthy subjects."],"dc:identifier":["https://digitalcommons.usu.edu/etd/4623"],"dc:identifier.doi":["https://doi.org/10.26076/700c-b10d"],"dc:publisher":["Hosted by Utah State University Libraries"],"dc:subject":["Gardner's Syndrome","autosomal dominant disease","natural killer cell","genetic defect","Biology","Genetics","Immunology and Infectious Disease"],"dc:title":["Natural Killer Activity in Gardner's Syndrome"],"thesis:degree_discipline":["Biology"],"thesis:degree_level":["Thesis"],"thesis:degree_name":["Master of Science (MS)"]},"updated_at":"2026-11-19T08:56:46Z"}